TY - JOUR AU - Hansen, H. H. PY - 2002 DA - 2002// TI - Treatment of advanced non-small cell lung cancer JO - Br Med J VL - 325 UR - https://doi.org/10.1136/bmj.325.7362.452 DO - 10.1136/bmj.325.7362.452 ID - Hansen2002 ER - TY - JOUR AU - Mendelsohn, J. PY - 2002 DA - 2002// TI - Targeting the epidermal growth factor receptor for cancer therapy JO - J Clin Oncol VL - 20 ID - Mendelsohn2002 ER - TY - JOUR AU - Habib, A. A. AU - Chun, S. J. AU - Neel, B. G. AU - Vartanian, T. PY - 2003 DA - 2003// TI - Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways JO - Mol Cancer Res VL - 1 ID - Habib2003 ER - TY - JOUR AU - Veale, D. AU - Kerr, N. AU - Gibson, G. J. AU - Harris, A. L. PY - 1989 DA - 1989// TI - Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer JO - Cancer Res VL - 49 ID - Veale1989 ER - TY - JOUR AU - Laskin, J. J. AU - Sandler, A. B. PY - 2004 DA - 2004// TI - Epidermal growth factor receptor: a promising target in solid tumours JO - Cancer Treat Rev VL - 30 UR - https://doi.org/10.1016/j.ctrv.2003.10.002 DO - 10.1016/j.ctrv.2003.10.002 ID - Laskin2004 ER - TY - JOUR AU - Mendelsohn, J. AU - Baselga, J. PY - 2006 DA - 2006// TI - Epidermal growth factor receptor targeting in cancer JO - Semin Oncol VL - 33 UR - https://doi.org/10.1053/j.seminoncol.2006.04.003 DO - 10.1053/j.seminoncol.2006.04.003 ID - Mendelsohn2006 ER - TY - JOUR AU - Hynes, N. E. AU - Lane, H. A. PY - 2005 DA - 2005// TI - ERBB receptors and cancer: the complexity of targeted inhibitors JO - Nat Rev Cancer VL - 5 UR - https://doi.org/10.1038/nrc1609 DO - 10.1038/nrc1609 ID - Hynes2005 ER - TY - JOUR AU - Gridelli, C. AU - De Marinis, F. AU - Di Maio, M. AU - Cortinovis, D. AU - Cappuzzo, F. AU - Mok, T. PY - 2011 DA - 2011// TI - Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: review of the evidence JO - Lung Cancer VL - 71 UR - https://doi.org/10.1016/j.lungcan.2010.12.008 DO - 10.1016/j.lungcan.2010.12.008 ID - Gridelli2011 ER - TY - JOUR AU - Sequist, L. V. AU - Martins, R. G. AU - Spigel, D. AU - Grunberg, S. M. AU - Spira, A. AU - Jänne, P. A. AU - Joshi, V. A. AU - McCollum, D. AU - Evans, T. L. AU - Muzikansky, A. AU - Kuhlmann, G. L. AU - Han, M. AU - Goldberg, J. S. AU - Settleman, J. AU - Iafrate, A. J. AU - Engelman, J. A. AU - Haber, D. A. AU - Johnson, B. E. AU - Lynch, T. J. PY - 2008 DA - 2008// TI - First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.14.8494 DO - 10.1200/JCO.2007.14.8494 ID - Sequist2008 ER - TY - JOUR AU - Taron, M. AU - Ichinose, Y. AU - Rosell, R. AU - Mok, T. AU - Massuti, B. AU - Zamora, L. AU - Mate, J. L. AU - Manegold, C. AU - Ono, M. AU - Queralt, C. AU - Jahan, T. AU - Sanchez, J. J. AU - Sanchez-Ronco, M. AU - Hsue, V. AU - Jablons, D. AU - Sanchez, J. M. AU - Moran, T. PY - 2005 DA - 2005// TI - Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-2618 DO - 10.1158/1078-0432.CCR-04-2618 ID - Taron2005 ER - TY - JOUR AU - Takano, T. AU - Ohe, Y. AU - Sakamoto, H. AU - Tsuta, K. AU - Matsuno, Y. AU - Tateishi, U. AU - Yamamoto, S. AU - Nokihara, H. AU - Yamamoto, N. AU - Sekine, I. AU - Kunitoh, H. AU - Shibata, T. AU - Sakiyama, T. AU - Yoshida, T. AU - Tamura, T. PY - 2005 DA - 2005// TI - Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.01.0793 DO - 10.1200/JCO.2005.01.0793 ID - Takano2005 ER - TY - JOUR AU - Wang, F. AU - Wang, S. AU - Wang, Z. AU - Duan, J. AU - An, T. AU - Zhao, J. AU - Bai, H. AU - Wang, J. PY - 2012 DA - 2012// TI - Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR JO - J Exp Clin Cancer Res VL - 31 UR - https://doi.org/10.1186/1756-9966-31-65 DO - 10.1186/1756-9966-31-65 ID - Wang2012 ER - TY - JOUR AU - Sequist, L. V. AU - Bell, D. W. AU - Lynch, T. J. AU - Haber, D. A. PY - 2007 DA - 2007// TI - Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.07.3585 DO - 10.1200/JCO.2006.07.3585 ID - Sequist2007 ER - TY - JOUR AU - Mitsudomi, T. AU - Kosaka, T. AU - Endoh, H. AU - Horio, Y. AU - Hida, T. AU - Mori, S. AU - Hatooka, S. AU - Shinoda, M. AU - Takahashi, T. AU - Yatabe, Y. PY - 2005 DA - 2005// TI - Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.00.992 DO - 10.1200/JCO.2005.00.992 ID - Mitsudomi2005 ER - TY - JOUR AU - Ma, C. AU - Wei, S. AU - Song, Y. PY - 2011 DA - 2011// TI - T790M and acquired resistance of EGFR TKI: a literature review of clinical reports JO - J Thorac Dis VL - 3 ID - Ma2011 ER - TY - JOUR AU - Lee, D. H. AU - Kim, S. W. AU - Suh, C. AU - Yoon, D. H. AU - Yi, E. J. AU - Lee, J. S. PY - 2008 DA - 2008// TI - Phase II study of erlotinib as a salvage treatment for non-small-cell lung cancer patients after failure of gefitinib treatment JO - Ann Oncol VL - 19 UR - https://doi.org/10.1093/annonc/mdn423 DO - 10.1093/annonc/mdn423 ID - Lee2008 ER - TY - BOOK PY - 1977 DA - 1977// TI - Zhongyao Dacidian (Encyclopedia of Chinese Materia Medica) PB - Shanghai Science and Technology Press CY - Shanghai ID - ref17 ER - TY - JOUR AU - Zhang, H. AU - Tan, A. M. AU - Zhang, A. Y. AU - Chen, R. AU - Yang, S. B. AU - Huang, X. PY - 2010 DA - 2010// TI - Five new C21 steroidal glycosides from the stems of Marsdenia tenacissima JO - Steroids VL - 75 UR - https://doi.org/10.1016/j.steroids.2009.11.003 DO - 10.1016/j.steroids.2009.11.003 ID - Zhang2010 ER - TY - JOUR AU - Luo, S. Q. AU - Lin, L. Z. AU - Cordell, G. A. AU - Xue, L. AU - Johnson, M. E. PY - 1993 DA - 1993// TI - Polyoxypregnanes from Marsdenia tenacissima JO - Phytochemistry VL - 34 UR - https://doi.org/10.1016/S0031-9422(00)90856-2 DO - 10.1016/S0031-9422(00)90856-2 ID - Luo1993 ER - TY - JOUR AU - Han, S. Y. AU - Zhao, M. B. AU - Zhuang, G. B. AU - Li, P. P. PY - 2012 DA - 2012// TI - Marsdenia tenacissima extract restored gefitinib sensitivity in resistant non-small cell lung cancer cells JO - Lung Cancer VL - 752 UR - https://doi.org/10.1016/j.lungcan.2011.06.001 DO - 10.1016/j.lungcan.2011.06.001 ID - Han2012 ER - TY - JOUR AU - Wang, W. Y. AU - Zhou, Y. AU - Zhang, X. J. AU - Gao, T. H. AU - Luo, Z. F. AU - Liu, M. Y. PY - 2009 DA - 2009// TI - A random study of xiao-ai-ping injection combined with chemotherapy on the treatment of advanced non-small cell lung cancer JO - Chin Clin Oncol VL - 14 ID - Wang2009 ER - TY - JOUR AU - Wang, K. AU - Guo, Z. X. PY - 2009 DA - 2009// TI - Xiaoaiping injection combining with NP regiment in the treatment of 56 Patients with advanced lung cancer JO - J Basic Clin Oncol VL - 22 ID - Wang2009 ER - TY - JOUR AU - Huang, Z. Q. AU - Tan, H. AU - Wang, C. Y. AU - Zhang, H. Z. AU - Liu, D. AU - Zhou, C. Z. AU - Liu, X. PY - 2007 DA - 2007// TI - Clinical research of combined xiaoaiping injection with chemotherapy on advanced non-small cell lung cancer JO - Chin Clinl Oncol VL - 12 ID - Huang2007 ER - TY - JOUR AU - Furugaki, K. AU - Iwai, T. AU - Shirane, M. AU - Kondoh, K. AU - Moriya, Y. AU - Mori, K. PY - 2010 DA - 2010// TI - Schedule-dependent antitumor activity of the combination with erlotinib and docetaxel in human non-small cell lung cancer cells with EGFR mutation, KRAS mutation or both wild-type EGFR and KRAS JO - Oncol Rep VL - 24 UR - https://doi.org/10.3892/or_00000965 DO - 10.3892/or_00000965 ID - Furugaki2010 ER - TY - JOUR AU - Shimoyama, T. AU - Koizumi, F. AU - Fukumoto, H. AU - Kiura, K. AU - Tanimoto, M. AU - Saijo, N. AU - Nishio, K. PY - 2006 DA - 2006// TI - Effects of different combinations of gefitinib and irinotecan in lung cancer cell lines expressing wild or deletional EGFR JO - Lung Cancer VL - 53 UR - https://doi.org/10.1016/j.lungcan.2006.03.014 DO - 10.1016/j.lungcan.2006.03.014 ID - Shimoyama2006 ER - TY - JOUR AU - Chou, T. C. PY - 2010 DA - 2010// TI - Drug combination studies and their synergy quantification using the Chou-Talalay method JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-1947 DO - 10.1158/0008-5472.CAN-09-1947 ID - Chou2010 ER - TY - JOUR AU - Baselga, J. AU - Rischin, D. AU - Ranson, M. AU - Calvert, H. AU - Raymond, E. AU - Kieback, D. G. AU - Kaye, S. B. AU - Gianni, L. AU - Harris, A. AU - Bjork, T. AU - Averbuch, S. D. AU - Feyereislova, A. AU - Swaisland, H. AU - Rojo, F. AU - Albanell, J. PY - 2002 DA - 2002// TI - Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types JO - J Clini Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.03.100 DO - 10.1200/JCO.2002.03.100 ID - Baselga2002 ER - TY - JOUR AU - Landi, L. AU - Minuti, G. AU - D’Incecco, A. AU - Cappuzzo, F. PY - 2013 DA - 2013// TI - Targeting c-MET in the battle against advanced nonsmall-cell lung cancer JO - Curr Opin Oncol VL - 25 UR - https://doi.org/10.1097/CCO.0b013e32835daf37 DO - 10.1097/CCO.0b013e32835daf37 ID - Landi2013 ER - TY - JOUR AU - Dulak, A. M. AU - Gubish, C. T. AU - Stabile, L. P. AU - Henry, C. AU - Siegfried, J. M. PY - 2011 DA - 2011// TI - HGF-independent potentiation of EGFR action by c-Met JO - Oncogene VL - 30 UR - https://doi.org/10.1038/onc.2011.84 DO - 10.1038/onc.2011.84 ID - Dulak2011 ER - TY - JOUR AU - Guo, A. AU - Villén, J. AU - Kornhauser, J. AU - Lee, K. A. AU - Stokes, M. P. AU - Rikova, K. AU - Possemato, A. AU - Nardone, J. AU - Innocenti, G. AU - Wetzel, R. AU - Wang, Y. AU - MacNeill, J. AU - Mitchell, J. AU - Gygi, S. P. AU - Rush, J. AU - Polakiewicz, R. D. AU - Comb, M. J. PY - 2008 DA - 2008// TI - Signaling networks assembled by oncogenic EGFR and c-Met JO - Proc Natl Acad Sci U S A VL - 105 UR - https://doi.org/10.1073/pnas.0707270105 DO - 10.1073/pnas.0707270105 ID - Guo2008 ER - TY - JOUR AU - Lemmon, M. A. AU - Schlessinger, J. PY - 2010 DA - 2010// TI - Cell signaling by receptor tyrosine kinases JO - Cell VL - 141 UR - https://doi.org/10.1016/j.cell.2010.06.011 DO - 10.1016/j.cell.2010.06.011 ID - Lemmon2010 ER - TY - JOUR AU - Ono, M. AU - Hirata, A. AU - Kometani, T. AU - Miyagawa, M. AU - Ueda, S. AU - Kinoshita, H. AU - Fujii, T. AU - Kuwano, M. PY - 2004 DA - 2004// TI - Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation JO - Mol Cancer Ther VL - 3 ID - Ono2004 ER - TY - JOUR AU - Zhao, J. PY - 2007 DA - 2007// TI - Nutraceuticals, nutritional therapy, phytonutrients, and phytotherapy for improvement of human health: a perspective on plant biotechnology application JO - Recent Pat Biotechnol VL - 1 UR - https://doi.org/10.2174/187220807779813893 DO - 10.2174/187220807779813893 ID - Zhao2007 ER - TY - JOUR AU - Lee, J. Y. AU - Lee, Y. M. AU - Chang, G. C. AU - Yu, S. L. AU - Hsieh, W. Y. AU - Chen, J. J. AU - Chen, H. W. AU - Yang, P. C. PY - 2011 DA - 2011// TI - Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0023756 DO - 10.1371/journal.pone.0023756 ID - Lee2011 ER - TY - JOUR AU - Chang, C. M. AU - Chang, P. Y. AU - Tu, M. G. AU - Lu, C. C. AU - Kuo, S. C. AU - Amagaya, S. AU - Lee, C. Y. AU - Jao, H. Y. AU - Chen, M. Y. AU - Yang, J. S. PY - 2012 DA - 2012// TI - Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2 JO - Oncol Rep VL - 28 ID - Chang2012 ER - TY - JOUR AU - Cheng, H. AU - An, S. J. AU - Dong, S. AU - Zhang, Y. F. AU - Zhang, X. C. AU - Chen, Z. H. AU - Su, J. AU - Wu, Y. L. PY - 2011 DA - 2011// TI - Molecular mechanism of the schedule-dependent synergistic interaction in EGFR-mutant non-small cell lung cancer cell lines treated with paclitaxel and gefitinib JO - J Hematol Oncol VL - 4 UR - https://doi.org/10.1186/1756-8722-4-5 DO - 10.1186/1756-8722-4-5 ID - Cheng2011 ER - TY - JOUR AU - Brognard, J. AU - Dennis, P. A. PY - 2002 DA - 2002// TI - Variable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants JO - Cell Death Differ VL - 9 UR - https://doi.org/10.1038/sj.cdd.4401054 DO - 10.1038/sj.cdd.4401054 ID - Brognard2002 ER - TY - JOUR AU - Méndez, M. AU - Custodio, A. AU - Provencio, M. PY - 2011 DA - 2011// TI - New molecular targeted therapies for advanced non-small-cell lung cancer JO - J Thorac Dis VL - 3 ID - Méndez2011 ER - TY - JOUR AU - Balsara, B. R. AU - Pei, J. AU - Mitsuuchi, Y. AU - Page, R. AU - Klein-Szanto, A. AU - Wang, H. AU - Unger, M. AU - Testa, J. R. PY - 2004 DA - 2004// TI - Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions JO - Carcinogenesis VL - 25 UR - https://doi.org/10.1093/carcin/bgh226 DO - 10.1093/carcin/bgh226 ID - Balsara2004 ER - TY - JOUR AU - Engelman, J. A. AU - Jänne, P. A. AU - Mermel, C. AU - Pearlberg, J. AU - Mukohara, T. AU - Fleet, C. AU - Cichowski, K. AU - Johnson, B. E. AU - Cantley, L. C. PY - 2005 DA - 2005// TI - ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines JO - Proc Natl Acad Sci U S A VL - 102 UR - https://doi.org/10.1073/pnas.0409773102 DO - 10.1073/pnas.0409773102 ID - Engelman2005 ER - TY - JOUR AU - Puri, N. AU - Salgia, R. PY - 2008 DA - 2008// TI - Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer JO - J Carcinog VL - 7 UR - https://doi.org/10.4103/1477-3163.44372 DO - 10.4103/1477-3163.44372 ID - Puri2008 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/14/165/prepub UR - http://www.biomedcentral.com/1472-6882/14/165/prepub ID - ref42 ER -